Dr. James M. Foran, MD

Dr. Foran practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Foran's NPI, 1992749139, was assigned on June 16, 2006. Dr. Foran graduated from University of Manitoba in 1990. Dr. Foran holds Florida license ME109499.

Dr. Foran's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Foran's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Foran practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Foran's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Foran is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Foran's licenses on file in 2 states: Florida and Alabama.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, fluid and electrolyte imbalances, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Foran treats.

CMS data shows 51,878 Medicare services from Dr. Foran across 51 procedure codes in 2024, for 782 Medicare patients. Medicare paid $789,854 for them.

CMS counts 782 Medicare patients who saw Dr. Foran in 2024. The largest group is 65 to 74, with 374 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 4% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Foran's median patient age at 66, with 48% women.

In 2024, Dr. Foran wrote 861 Medicare Part D claims for 117 patients. 73% of them were for generic drugs. CMS names the drug for 548 of them, across 24 drugs with 11 or more claims each, at $1,730,721 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Foran for performance year 2024, reported as part of a group. Dr. Foran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Foran as offering telehealth.

Dmand AI links 170 papers to Dr. Foran, published from 2009 to 2025. 2023 was the busiest year, with 18. The most frequent topics are Leukemia, Myeloid, Acute, Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation. Dr. Foran has published most often in Am J Hematol. Dr. Foran's most frequent co-authors are Aref Al-Kali, MD, Hassan B. Alkhateeb, MD and Mark R. Litzow, MD.

Dmand AI links Dr. Foran to 6 clinical trials, 2 of them phase 1 studies. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Leukemia-Lymphoma, Adult T-Cell. University of Alabama at Birmingham sponsors the most, 2.

CMS Open Payments shows 35 general payments to Dr. Foran from 7 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 65% of the total. Syndax Pharmaceuticals, Inc. paid the most, $11,640.

Dmand AI lists 1 award for Dr. Foran, most recently Regional Top Doctor in 2014.

Dr. Foran graduated from University of Manitoba in 1990.

Dr. Foran is in network with 8 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.